Interestingly, a reduced expression of TGF-βR2 in HCC correlates with larger tumor size and various metastatic features, such as poor differentiation, portal vein invasion, and intrahepatic metastases [49,50]. Here, TGFBR2 is linked to hepatocellular carcinoma.